NeoGenomics is an industry-leading cancer diagnostics and pharma services company. NeoGenomics Pharma Services provide one of the most comprehensive biomarker test menus available for Oncology, Immuno-Oncology, Infectious Diseases and Vaccines. We partner closely with our pharma and research clients to meet program objectives and delivery, from biomarker discovery through CDx validation and commercialization.

NeoGenomics have a global (CLIA/CAP) laboratory network in US, Switzerland, Singapore and China.

Pharma Services:

Standardized PBMC Processing across regions (US, EU, Asia-Pac)
Flow Cytometry including Receptor Occupancy (RO), surface and intra markers, in vitro re-stimulation
Immunoassay development by ELISA and Luminex platforms
Cytokine testing-design of customized panels and pre-validated panels
Molecular testing by NGS, q-PCR, RT-PCR, Nanostring - Cancer and Infectious diseases such as Influenza, SARS-CoV-2; Dengue, HIV, RSV, CHIKV across a large list of viruses

NeoGenomics are proud to be part of the COVID-19 Testing Industry Consortium

CANCELLED: Development of a personalized dendritic cell vaccine

Information

Log in